IMVT short interest
Immunovant Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 17,416,613 |
|---|---|
| Change vs prior report | 162,665 (+0.9%) |
| Change over six months | -5.5% |
| Days to cover | 9.64 (sector: 3.78) |
| Average daily volume | 1,805,887 |
| Rank in Healthcare | #122 of 922 by days to cover |
IMVT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 17,416,613 | +0.9% | 9.64 | 1,805,887 |
| 2026-09-15 | 17,253,948 | +9.3% | 14.34 | 1,203,127 |
| 2026-08-31 | 15,784,450 | -7.0% | 14.05 | 1,123,305 |
| 2026-08-14 | 16,981,939 | +3.7% | 15.07 | 1,126,554 |
| 2026-07-31 | 16,375,679 | -7.8% | 18.52 | 884,266 |
| 2026-07-15 | 17,758,956 | -1.3% | 16.72 | 1,062,352 |
| 2026-06-30 | 17,991,218 | -7.0% | 8.63 | 2,085,654 |
| 2026-06-15 | 19,342,026 | +0.7% | 14.09 | 1,373,064 |
| 2026-05-29 | 19,208,923 | -5.7% | 4.99 | 3,848,981 |
| 2026-05-15 | 20,368,530 | +9.6% | 16.36 | 1,244,653 |
| 2026-04-30 | 18,590,270 | -4.7% | 10.49 | 1,772,681 |
| 2026-04-15 | 19,500,601 | +5.8% | 13.82 | 1,410,622 |
| 2026-03-31 | 18,430,920 | +11.3% | 12.36 | 1,491,046 |
| 2026-03-13 | 16,565,490 | -1.6% | 16.11 | 1,028,071 |
| 2026-02-27 | 16,835,365 | -0.7% | 19.20 | 877,005 |
| 2026-02-13 | 16,951,530 | +2.8% | 10.18 | 1,665,252 |
| 2026-01-30 | 16,487,739 | -2.6% | 13.12 | 1,256,815 |
| 2026-01-15 | 16,933,015 | +4.9% | 9.72 | 1,742,359 |
| 2025-12-31 | 16,135,139 | +7.8% | 9.77 | 1,650,816 |
| 2025-12-15 | 14,964,704 | -0.7% | 7.15 | 2,092,455 |
| 2025-11-28 | 15,067,824 | -8.0% | 12.78 | 1,178,809 |
| 2025-11-14 | 16,381,611 | +1.0% | 10.11 | 1,620,865 |
| 2025-10-31 | 16,214,977 | -4.7% | 7.27 | 2,230,403 |
| 2025-10-15 | 17,009,989 | +4.6% | 11.49 | 1,479,864 |
| 2025-09-30 | 16,268,540 | +0.8% | 8.79 | 1,849,964 |
import finzdata as yf
yf.Ticker("IMVT").short_interest # every report since 2017
yf.Client().short_interest(["IMVT"], start="2018-01-01")Healthcare short interest · IMVT price history · Who owns IMVT · All short interest